Glutamate plays an important metabolic role in virtually every vertebr
ate cell. In particular, glutamate is the most common excitatory neuro
transmitter in the vertebrate central nervous system. As such, the mec
hanism by which glutamate is diverted from its normal metabolic activi
ties toward its role as a neurotransmitter has, in recent years, been
systematically investigated. In glutamatergic nerve endings, synaptic
vesicles accumulate and store a proportion of the cellular glutamate p
ool and, in response to appropriate signals, release glutamate into th
e synaptic cleft by exocytosis. Glutamate accumulation is accomplished
by virtue of a glutamate uptake system present in the synaptic vesicl
e membrane. The uptake system consists of a transport protein, remarka
bly specific for glutamate, and a vacuolar-type H+-ATPase, which provi
des the coupling between ATP hydrolysis and glutamate transport. The p
recise manner in which the glutamate transporter and H+-ATPase operate
is currently the subject of debate. Recent data relevant to this deba
te are reviewed in this article. Additionally, pharmacological agents
thought to specifically interact with the vesicular glutamate transpor
ter are discussed. Finally, a newly discovered, endogenous inhibitor o
f vesicular uptake, inhibitory protein factor (IPF), is discussed with
some speculations as to its potential role as a presynaptic modulator
of neurotransmission.